Papapetropoulos Spyridon 4
4 · Adamas Pharmaceuticals Inc · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Director
Transactions
- Purchase
Common Stock
2021-03-11$5.06/sh+5,975$30,233→ 15,975 total
Footnotes (1)
- [F1]The shares were purchased at prices ranging from $4.85 to $5.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.